
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Author(s) -
E.E. Tolley,
S.Z. Zangeneh,
G. Chau,
JJ Eron,
B. Grinsztejn,
H. Humphries,
A. Liu,
M. Siegel,
M. Bertha,
R. Panchia,
S. Li,
L. Cottle,
A. Rinehart,
D. Margolis,
A. Jennings,
M. McCauley,
R.J. Landovitz
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/nwrk-cv03
Subject(s) - human immunodeficiency virus (hiv) , virology , medicine , pharmacology